Accuri Cytometers locks down $6M in financing, adds 25 positions

Wednesday, July 21, 2010 | Source: Concentrate

Accuri Cytometers, an A-list start-up from Ann Arbor, is pulling in seven figures' worth of seed capital this month.

The company is bringing in $6 million in financing to be used to take its Accuri C6 Flow Cytometer into clinical trials and push it towards commercialization. That should allow it to continue growing at a rapid clip. The company has hired about 25 people over the last year, expanding its staff to 87 employees and a few independent contractors and interns.

"Our revenue is growing rapidly," says Jeff Williams, CEO of Accuri Cytometers. "Our sales are growing rapidly."

Accuri Cytometers, a University of Michigan spin-off, specializes in making the cytometer systems that measure T-cell counts (among other things), which is an instrumental tool in tracking and treating diseases like AIDS and cancer. It is a research field with lots of room to grow in both the near and long term.

The firm has been on a tear in recent months, selling its products worldwide. It has attracted a number of new customers.

"We expects our growth rate to continue," Williams says.

Source: Jeff Williams, CEO of Accuri Cytometers
Writer: Jon Zemke

Related Company

Accuri Cytometers
173 Parkland Plaza
Ann Arbor, MI 48103 Website

You may not know what a cytometer does, but here's what it means for Ann Arbor-based Accuri: jobs, growth, and expansion. And what's good for the goose is good for the gander (A2).
University of Michigan
Ann Arbor, Michigan Website